All Stories

  1. Racial and Ethnic Differences in the Determinants of Antibiotic Use for Acute Gastroenteritis in the United States

    Article • February 2026, openRxiv

    Dr Gillian Tarr

  2. Emergency Department Visits During the Fall 2019 Public Safety Power Shutoff Events in California

    Article • Disaster Medicine and Public Health Preparedness, January 2026, Cambridge University Press

    Dr Gillian Tarr

  3. Only Who Can Prevent Forest Fires? Causes of a Subset of Wildfires in California, 2010–2021

    Article • Natural Hazards Review, November 2025, American Society of Civil Engineers (ASCE)

    Dr Gillian Tarr

  4. Locally persistent lineages are an important component of zoonotic foodborne pathogen Shiga toxin-producing Escherichia coli O157:H7 disease ecology

    Article • October 2025, Cold Spring Harbor Laboratory Press

    Dr Gillian Tarr

  5. The association of Public Safety Power Shutoffs and motor vehicle crashes

    Article • Journal of Safety Research, July 2025, Elsevier

    Dr Gillian Tarr

  6. Compound drought and heatwave extreme weather events: Mortality risk in individuals with chronic respiratory disease

    Article • Environmental Epidemiology, May 2025, Wolters Kluwer Health

    Dr Gillian Tarr

  7. Ruminant-dense environments increase risk of reported Shiga toxin-producing Escherichia coli infections independently of ruminant contact

    Article • Applied and Environmental Microbiology, February 2025, ASM Journals

    Dr Gillian Tarr

  8. Comorbidities, Tobacco Exposure, and Geography: Added Risk Factors of Heat and Cold Wave–related Mortality among U.S. Veterans with Chronic Obstructive Pulmonary Disease

    Article • Annals of the American Thoracic Society, February 2025, American Thoracic Society

    Dr Gillian Tarr

  9. Persistent cross-species transmission systems dominate Shiga toxin-producing Escherichia coli O157:H7 epidemiology in a high incidence region: A genomic epidemiology study

    Article • eLife, January 2025, eLife

    Dr Gillian Tarr

  10. Persistent cross-species transmission systems dominate Shiga toxin-producing Escherichia coli O157:H7 epidemiology in a high incidence region: a genomic epidemiology study

    Article • January 2025, eLife

    Dr Gillian Tarr

  11. Psychological distress as a driver of early COVID-19 pandemic fatigue: a longitudinal analysis of the time-varying relationship between distress and physical distancing adherence among families with children and older adults

    Article • BMJ Public Health, November 2024, BMJ

    Dr Gillian Tarr

  12. Ruminant-dense environments increase risk of Shiga toxin-producingEscherichia coliindependently of ruminant contact

    Article • September 2024, Cold Spring Harbor Laboratory Press

    Dr Gillian Tarr

  13. Genetic Determinants of Disease Transmission: Using Gradient Boosted Decision Trees to Identify Shiga Toxin-Producing Escherichia coli Genes Associated with Specific Risk Factors

    Article • Annals of Epidemiology, September 2024, Elsevier

    Dr Gillian Tarr

  14. Persistent cross-species transmission systems dominate Shiga toxin-producing Escherichia coli O157:H7 epidemiology in a high incidence region: a genomic epidemiology study

    Article • August 2024, eLife

    Dr Gillian Tarr

  15. Persistent cross-species transmission systems dominate Shiga toxin-producing Escherichia coli O157:H7 epidemiology in a high incidence region: a genomic epidemiology study

    Article • August 2024, eLife

    Dr Gillian Tarr

  16. Social Behaviors Associated with SARS-CoV-2 Test Positivity Among Children Evaluated in Canadian Emergency Departments, 2020 to 2022: A Cross-Sectional Survey Study

    Article • Academic Pediatrics, August 2024, Elsevier

    Dr Gillian Tarr

  17. Farm Animal Exposure Setting Impacts Hemolytic Uremic Syndrome Risk Among Cases Infected with Shiga toxin-producing Escherichia coli — Minnesota, 2010-2019

    Article • Epidemiology and Infection, May 2024, Cambridge University Press

    Dr Gillian Tarr

  18. Persistent cross-species transmission systems dominate Shiga toxin-producingEscherichia coliO157:H7 epidemiology in a high incidence region: a genomic epidemiology study

    Article • April 2024, Cold Spring Harbor Laboratory Press

    Dr Gillian Tarr

  19. Heat and Cold Wave–Related Mortality Risk among United States Veterans with Chronic Obstructive Pulmonary Disease: A Case-Crossover Study

    Article • Environmental Health Perspectives, February 2024, Environmental Health Perspectives

    Dr Gillian Tarr

  20. Differences in risk factors for transmission among Shiga toxin-producing Escherichia coli serogroups and stx profiles

    Article • Journal of Infection, December 2023, Elsevier

    Dr Gillian Tarr

  21. Molecular epidemiology of rotavirus among children in Western Canada: Dynamic changes in genotype prevalence in four consecutive seasons

    Article • Journal of Medical Virology, August 2023, Wiley

    Dr Gillian Tarr

  22. Sociodemographic effects on pandemic fatigue are multifaceted and context-specific: A longitudinal analysis of physical distancing adherence

    Article • July 2023, SAGE Publications

    Dr Gillian Tarr

  23. Enteric Pathogen Testing Importance for Children with Acute Gastroenteritis: a Modified Delphi Study

    Article • Microbiology Spectrum, September 2022, ASM Journals

    Dr Gillian Tarr

  24. Genomic Analysis of Shiga Toxin-Producing E. coli O157 Cattle and Clinical Isolates from Alberta, Canada

    Article • Toxins, August 2022, MDPI AG

    Dr Gillian Tarr

  25. Personal factors affect physical distancing differently based on demographic characteristics

    Article • PLOS One, May 2022, PLOS

    Dr Gillian Tarr, Gillian Tarr

  26. Detection and Clinical Implications of Monovalent Rotavirus Vaccine-Derived Virus Strains in Children with Gastroenteritis in Alberta, Canada

    Article • Journal of Clinical Microbiology, October 2021, ASM Journals

    Dr Gillian Tarr

  27. Prevalence of Detection of Clostridioides difficile Among Asymptomatic Children

    Article • JAMA Pediatrics, October 2021, American Medical Association (AMA)

    Dr Gillian Tarr

  28. Clinical Profiles of Childhood Astrovirus-, Sapovirus-, and Norovirus-Associated Acute Gastroenteritis in Pediatric Emergency Departments in Alberta, 2014–2018

    Article • The Journal of Infectious Diseases, August 2021, Oxford University Press (OUP)

    Dr Gillian Tarr

  29. Predicting Adverse Outcomes for Shiga Toxin–Producing Escherichia coli Infections in Emergency Departments

    Article • The Journal of Pediatrics, May 2021, Elsevier

    Dr Gillian Tarr

  30. Pediatric Enteric Diagnostic Stewardship: The Right Test in the Right Context

    Article • PEDIATRICS, April 2021, American Academy of Pediatrics (AAP)

    Dr Gillian Tarr

  31. Farm animal contact is associated with progression to Hemolytic uremic syndrome in patients with Shiga toxin-producing Escherichia coli — Indiana, 2012–2018

    Article • One Health, December 2020, Elsevier

    Dr Gillian Tarr

  32. Association of Ct Values from Real-Time PCR with Culture in Microbiological Clearance Samples for Shiga Toxin-Producing Escherichia coli (STEC)

    Article • Microorganisms, November 2020, MDPI AG

    Dr Gillian Tarr

  33. Influenza virus detection in the stool of children with acute gastroenteritis

    Article • Journal of Clinical Virology, October 2020, Elsevier

    Dr Gillian Tarr

  34. Attribution of Pediatric Acute Gastroenteritis Episodes and Emergency Department Visits to Norovirus GI and GII

    Article • The Journal of Infectious Diseases, July 2020, Oxford University Press (OUP)

    Dr Gillian Tarr

  35. Diagnostic Test Accuracy of Commercial Tests for Detection of Shiga Toxin–Producing Escherichia coli: A Systematic Review and Meta-Analysis

    Article • Clinical Chemistry, January 2020, Oxford University Press (OUP)

    Dr Gillian Tarr

  36. Contribution and Interaction of Shiga Toxin Genes to Escherichia coli O157:H7 Virulence

    Article • Toxins, October 2019, MDPI AG

    Dr Gillian Tarr

  37. Clinical interpretation of enteric molecular diagnostic tests

    Article • Clinical Microbiology and Infection, September 2019, Elsevier

    Dr Gillian Tarr

  38. Pigment Visibility on Rectal Swabs Used To Detect Enteropathogens: a Prospective Cohort Study

    Article • Journal of Clinical Microbiology, April 2019, ASM Journals

    Dr Gillian Tarr

  39. Performance of commercial tests for molecular detection of Shiga toxin-producing Escherichia coli (STEC): a systematic review and meta-analysis protocol

    Article • BMJ Open, March 2019, BMJ

    Dr Gillian Tarr

  40. Importance of case age in the purported association between phylogenetics and hemolytic uremic syndrome in Escherichia coli O157:H7 infections – ERRATUM

    Article • Epidemiology and Infection, January 2019, Cambridge University Press

    Dr Gillian Tarr

  41. Performance of Stool Testing Recommendations for Acute Gastroenteritis when Used to Identify Children with Nine Potential Bacterial Enteropathogens

    Article • Clinical Infectious Diseases, December 2018, Oxford University Press (OUP)

    Dr Gillian Tarr

  42. Case definitions of hemolytic uremic syndrome following Escherichia coli O157:H7 infection vary in validity

    Article • International Journal of Medical Microbiology, October 2018, Elsevier

    Dr Gillian Tarr

  43. Linking Provincial and Prospective Cohort Study Data to Estimate the Incidence and Healthcare Burden of Viral Gastroenteritis

    Article • International Journal for Population Data Science, September 2018, Swansea University

    Dr Gillian Tarr

  44. Importance of case age in the purported association between phylogenetics and hemolytic uremic syndrome in Escherichia coli O157:H7 infections

    Article • Epidemiology and Infection, June 2018, Cambridge University Press

    Dr Gillian Tarr

  45. Strength of the association between antibiotic use and hemolytic uremic syndrome following Escherichia coli O157:H7 infection varies with case definition

    Article • International Journal of Medical Microbiology, June 2018, Elsevier

    Dr Gillian Tarr

  46. The health, poverty, and financial consequences of a cigarette price increase among 500 million male smokers in 13 middle income countries: compartmental model study

    Article • BMJ, April 2018, BMJ

    Dr Gillian Tarr

  47. Geogenomic Segregation and Temporal Trends of Human Pathogenic Escherichia coli O157:H7, Washington, USA, 2005–20141

    Article • Emerging Infectious Diseases, January 2018, Centers for Disease Control and Prevention (CDC)

    Dr Gillian Tarr

  48. The Health Gains, Financial Risk Protection Benefits, and Distributional Impact of Increased Tobacco Taxes in Armenia

    Article • Health Systems & Reform, December 2017, Taylor & Francis

    Dr Gillian Tarr

  49. Distributional benefits of tobacco tax and smoke–free workplaces in China: A modeling study

    Article • Journal of Global Health, November 2017, Edinburgh University Global Health Society

    Dr Gillian Tarr

  50. Estimating the Distributional Impact of Increasing Taxes on Tobacco Products in Armenia

    Article • April 2017, World Bank

    Dr Gillian Tarr

  51. Strengthening paper health register systems: strategies from case studies in Ethiopia, Ghana, South Africa and Uganda

    Article • Journal of Global Health, March 2016, Edinburgh University Global Health Society

    Dr Gillian Tarr

  52. Systematic review and meta-analysis of community and facility-based HIV testing to address linkage to care gaps in sub-Saharan Africa

    Article • Nature, December 2015, Springer Science + Business Media

    Dr Gillian Tarr

  53. Using a Bayesian Latent Class Model to Evaluate the Utility of Investigating Persons with Negative Polymerase Chain Reaction Results for Pertussis

    Article • American Journal of Epidemiology, June 2013, Oxford University Press (OUP)

    Dr Gillian Tarr

  54. Reminder Cards and Immunization Rates Among Latinos and the Rural Poor in Northeast Colorado

    Article • The Journal of the American Board of Family Medicine, November 2007, American Board of Family Medicine (ABFM)

    Dr Gillian Tarr